ERAS

Conviction 65HealthcareScan · Thu, Jun 25, 2026

ERAS$14.94-0.76%

ResistanceSupportVol 14

Vol MA14 5.97M

Mar 26Apr 14May 1May 19Jun 8Jun 25

Erasca, Inc.PHARMACEUTICAL PREPARATIONSwww.erasca.com ↗

Price14.94

Change-0.76%

Gap+0.27%

Rel volume3.01×

Avg volume6.21M

Avg $ vol85.8M

SMA 2013.70

SMA 5013.60

SMA 2008.82

Price vs 50+9.81%

Price vs 200+69.36%

MA stackbullish

50/200 cross—

Supertrendup · 11.86

RSI (14)60

MACD hist0.20

MACD cross—

Stoch %K / %D79 / 81

ADX (14)18

+DI / −DI22 / 15

RSI divergence—

MACD divergence—

ATR %+7.37%

ADR %7.89%

52w high22.47

52w low1.26

From 52w high-33.53%

Above 52w low+1085.32%

New 52w highNo

SqueezeOff

Bollinger width25.65%

%B0.85

Donchian pos79.34%

Donchian high15.75

Donchian low11.81

AVWAP (52w high)12.87

vs AVWAP high+16.05%

AVWAP (52w low)10.47

vs AVWAP low+42.68%

OBV trendFlat

Chaikin MF (20)-0.09

Today vs 20d3.01×

Avg vol (14d)5.97M

Avg vol (20d)6.21M

Avg $ vol (20d)85.8M

Market cap4.64B

RS 3m (vs SPY)-9.67%

RS 6m (vs SPY)+328.50%

RS line new highNo

Trend template6/8

Technical rank91.2

1 week+6.83%

1 month+29.87%

3 months-6.60%

6 months+309.18%

1 year+930.00%

YTD+316.02%

P/E-37.29

P/B11.80

P/S—

P/FCF-48.59

EPS-0.4400

Div yield—

ROE-31.65%

ROA-27.00%

Debt/Eq—

Current9.52

EV/EBITDA-33.36

Gross margin—

Net margin—

Rev growth—

EPS growth22.95%

Price target22.25

Target upside48.98%

Analyst ratingBuy

Institutional92.12%

Ent. value4.6B

Revenue—

Net income-183.44M

Gross profit—

Free cash flow-95.58M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out310.98M

Employees103

ListedFri, Jul 16, 2021

Free float219.65M

Float %77.4%

Short interest31.89M

Days to cover7.5d

Short volume47.2%

Squeeze score74 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.11 vs −$0.19

Last surprise+42.1% beat

Setup gradeB

Conviction65 / 100

Pattern quality—

Tech rank91.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.39

Support9.79

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ERAS

All disclosures →

No recent disclosed trades by Congress in ERAS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ERAS

No recent insider (Form 4) filings in ERAS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ERAS · 1 recent

EDGAR →

144144Mon, Jun 15, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.